Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

High resolution quantitative computed tomography-based assessment of trabecular microstructure and strength estimates by finite-element analysis of the spine, but not DXA, reflects vertebral fracture status in men with glucocorticoid-induced osteoporosis

(2012) Christian Graeff et al.   BONE

The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis

(2012) Pawel Szulc   CLINICAL BIOCHEMISTRY

Male–female differences in the association between incident hip fracture and proximal femoral strength: A finite element analysis study

(2011) J.H. Keyak et al.   BONE

Femoral strength in osteoporotic women treated with teriparatide or alendronate

(2011) Tony M. Keaveny et al.   BONE

Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence

(2011) Richard Eastell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Association of hip strength estimates by finite-element analysis with fractures in women and men

(2011) Shreyasee Amin et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans

(2011) Xiang Wang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

QCT-based finite element models predict human vertebral strength in vitro significantly better than simulated DEXA

(2011) E. Dall’Ara et al.   OSTEOPOROSIS INTERNATIONAL

New Imaging Modalities in Bone

(2011) James F. Griffith et al.   Current Rheumatology Reports

Biomechanical computed tomography-noninvasive bone strength analysis using clinical computed tomography scans

(2010) Tony M. Keaveny   Annals of the New York Academy of Sciences

Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate

(2010) Richard Eastell et al.   BONE

Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate

(2010) Alan L. Burshell et al.   BONE

PINP as an aid for monitoring patients treated with teriparatide

(2010) Mika Tsujimoto et al.   BONE

Bone strength measured by peripheral quantitative computed tomography and the risk of nonvertebral fractures: The osteoporotic fractures in men (MrOS) study

(2010) Yahtyng Sheu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Finite element analysis performed on radius and tibia HR-pQCT images and fragility fractures at all sites in men

(2010) Nicolas Vilayphiou et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

(2010) Richard Eastell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Utility of Changes in Serum Levels of C-Terminal Telopeptide of Type I Collagen in Predicting Patient Response to Oral Monthly Ibandronate Therapy

(2010) Marc C. Hochberg et al.   JOURNAL OF CLINICAL DENSITOMETRY

Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis

(2010) J. J. Stepan et al.   OSTEOPOROSIS INTERNATIONAL

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide

(2010) A. Blumsohn et al.   OSTEOPOROSIS INTERNATIONAL

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

(2010) S. Vasikaran et al.   OSTEOPOROSIS INTERNATIONAL

Rapid and robust response of biochemical markers of bone formation to teriparatide therapy

(2009) Sarah J. Glover et al.   BONE

Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: Results from quantitative computed tomography-based finite element analysis of the vertebral body

(2009) Yan Chevalier et al.   BONE

Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity

(2009) Robert S. Weinstein   BONE

Improvements in Vertebral Body Strength Under Teriparatide Treatment Assessed In Vivo by Finite Element Analysis: Results From the EUROFORS Study

(2009) Christian Graeff et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis

(2009) Pierre D Delmas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis*

(2009) Robert R Recker et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Minireview: Live and Let Die: Molecular Effects of Glucocorticoids on Bone Cells

(2009) Lorenz C. Hofbauer et al.   MOLECULAR ENDOCRINOLOGY

Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years

(2009) O. Bruyère et al.   OSTEOPOROSIS INTERNATIONAL

A patient-specific finite element methodology to predict damage accumulation in vertebral bodies under axial compression, sagittal flexion and combined loads

(2008) Yan Chevalier et al.   COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING